Interferon alpha/beta Receptor 1 (IFNAR1) Peptide
IFNAR1
Reactivité: Humain
Hôte: Synthetic
BP, BI
-
- Antigène Tous les produits IFNAR1
- IFNAR1 (Interferon alpha/beta Receptor 1 (IFNAR1))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Attributs du produit
- IFNAR1 peptide corresponds to 12 amino acids of IFNAR1.
-
-
- Indications d'application
- IFNAR1 peptide is used for blocking the activity of IFNAR1 antibody . The IFNAR1 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- IFNAR1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
- Antigène
- IFNAR1 (Interferon alpha/beta Receptor 1 (IFNAR1))
- Synonymes
- ifnar1 Peptide, IFNAR1 Peptide, CD118 Peptide, Ifar Peptide, Ifnar Peptide, Ifrc Peptide, Infar Peptide, AVP Peptide, IFN-alpha-REC Peptide, IFNAR Peptide, IFNBR Peptide, IFRC Peptide, IFN-R-1 Peptide, interferon alpha and beta receptor subunit 1 Peptide, interferon-alpha/beta receptor alpha chain-like Peptide, interferon (alpha and beta) receptor 1 Peptide, interferon alpha/beta receptor 1 Peptide, IFNAR1 Peptide, ifnar1 Peptide, Ifnar1 Peptide, LOC609830 Peptide
- ID gène
- 3454
- NCBI Accession
- NP_000620
- OMIM
- 90110827
- UniProt
- P17181
-
Vous êtes ici:
